Caldwell Sutter Capital, Inc. Glaukos Corp Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q3 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 3,913 shares of GKOS stock, worth $611,954. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,913
Previous 3,913
-0.0%
Holding current value
$611,954
Previous $463 Million
10.08%
% of portfolio
0.24%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
345Shares Held
46.6MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$918 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$342 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$306 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$257 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.44B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...